Race Oncology Health Care
Cancer Chemotherapy Imaging Medical Radiology

$1.23 -0.02 (-1.21%)

High $1.29	Low $1.18	Trades 155	Turnover $303,224	Volume 249,053
30 June 2023 at 4:10pm

Market Cap (4-Aug) $385,275,488 (417th)	Close (30-Jun) $1.23 0 (0%)	Volume (30-Jun) 249,053	Shortsold (29-Jul) 19,354 (0.01%) (572nd)
52w High $4.90	52w Low $1.14	P/E -	EPS -0.05

Short Interest

ASIC data, 29 Jul 2026

% Shorted

0.01%

vs 0.01% prior report

Most Shorted Rank

572nd

of 717 shorted ASX stocks

Peak Short

0.05%

Dec 2021

Days to Cover

0.2

at 50d avg vol

View full short position history →

	Subject
	RAC RAC Ann: Cleansing Notice
	1 (current) 2 3
	RAC RAC Ann: Appendix 2A
	RAC RAC Ann: Race to recruit new Chief Medical Officer
	RAC RAC Ann: Initial Director's Interest Notice
	RAC RAC Ann: Mary Harney appointed Non-Executive Director of Race
	RAC RAC Ann: Quarterly Activity Report & Appendix 4C
	RAC RAC Ann: Cleansing Notice
	RAC RAC Ann: Appendix 2A
	RAC RAC Ann: Race receives $387k R&D tax incentive refund
	RAC RAC Ann: Race releases 2020 AGM presentation video
	RAC RAC Ann: Cleansing Notice
	RAC RAC Ann: Appendix 2A
	RAC RAC Ann: Final Director's Interest Notice
	RAC RAC Ann: Prof Andersson resigns from Board to focus on CMO role
	RAC RAC Ann: Change in substantial holding
	RAC RAC Ann: Appendix 3Y-Prof Borje Andersson
	RAC RAC Ann: Appendix 3Y-Daniel Tillett
	RAC RAC Ann: Appendix 3Y-Phillip Lynch
	RAC RAC Ann: Appendix 3Gs
	RAC RAC Ann: Replacement Constitution
	RAC RAC Ann: Results of Meeting
	RAC RAC Ann: Race AGM presentations and strategic update
	RAC RAC Ann: Breast Cancer Clinical Trial Program Initiated
	RAC RAC Ann: Impressive Preclinical Bisantrene Breast Cancer Results
	RAC RAC Ann: Cleansing Notice
	RAC RAC Ann: Appendix 2A-Exercise of Options
	RAC RAC Ann: Bisantrene data published in European Journal of Haematology
	RAC RAC Ann: Phase II Bisantrene trial data to be presented at ASH 2020
	RAC RAC Ann: Quarterly Activity Report & Appendix 4C
	RAC RAC Ann: Annual Report to Shareholders
	RAC RAC Ann: Letter to Shareholders, Notice of AGM & Proxy Form
	RAC RAC Ann: Appendix 3Z-Chris Ntoumenopoulos
	RAC RAC Ann: Appendix 3Z- Bill Garner
	RAC RAC Ann: Director Resignations

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
04-Aug	$1.97	121,750	+0.02 (0.77%)
03-Aug	$1.95	109,946	0.00 (0.00%)
31-Jul	$1.95	80,649	+0.02 (1.04%)
30-Jul	$1.93	129,057	-0.06 (3.02%)
29-Jul	$1.99	149,816	-0.05 (2.45%)
28-Jul	$2.04	49,460	-0.03 (1.45%)
27-Jul	$2.07	42,130	+0.02 (0.98%)
24-Jul	$2.05	44,444	0.00 (0.00%)
23-Jul	$2.05	73,714	0.00 (0.00%)
22-Jul	$2.05	94,292	+0.01 (0.49%)
21-Jul	$2.04	87,502	+0.04 (2.00%)
20-Jul	$2.00	92,443	-0.13 (6.10%)
17-Jul	$2.13	89,546	-0.44 (17.12%)
18-Sep	$2.57	834,409	+0.96 (59.63%)
12-Sep	$1.61	161,062	+0.03 (1.58%)
7 up, 5 down, and 3 flat days

Race Oncology Health Care
Cancer Chemotherapy Imaging Medical Radiology

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Race Oncology Health Care Cancer Chemotherapy Imaging Medical Radiology

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Race Oncology Health Care
Cancer Chemotherapy Imaging Medical Radiology